Structure

Physi-Chem Properties

Molecular Weight:  378.07
Volume:  364.157
LogP:  4.388
LogD:  3.105
LogS:  -5.757
# Rotatable Bonds:  1
TPSA:  120.36
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.368
Synthetic Accessibility Score:  3.271
Fsp3:  0.095
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.969
MDCK Permeability:  9.068874533113558e-06
Pgp-inhibitor:  0.021
Pgp-substrate:  0.009
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.271
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  94.46620178222656%
Volume Distribution (VD):  0.563
Pgp-substrate:  10.350072860717773%

ADMET: Metabolism

CYP1A2-inhibitor:  0.912
CYP1A2-substrate:  0.218
CYP2C19-inhibitor:  0.557
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.748
CYP2C9-substrate:  0.919
CYP2D6-inhibitor:  0.386
CYP2D6-substrate:  0.456
CYP3A4-inhibitor:  0.34
CYP3A4-substrate:  0.116

ADMET: Excretion

Clearance (CL):  16.081
Half-life (T1/2):  0.718

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.21
Drug-inuced Liver Injury (DILI):  0.979
AMES Toxicity:  0.638
Rat Oral Acute Toxicity:  0.891
Maximum Recommended Daily Dose:  0.895
Skin Sensitization:  0.952
Carcinogencity:  0.646
Eye Corrosion:  0.003
Eye Irritation:  0.933
Respiratory Toxicity:  0.345

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC28589

Natural Product ID:  NPC28589
Common Name*:   Anastatin B
IUPAC Name:   (2S)-5,9,10-trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-[1]benzofuro[2,3-h]chromen-4-one
Synonyms:  
Standard InCHIKey:  ZXWMKYBQWBZFAK-INIZCTEOSA-N
Standard InCHI:  InChI=1S/C21H14O7/c22-10-3-1-9(2-4-10)16-7-14(25)20-15(26)8-18-19(21(20)28-16)11-5-12(23)13(24)6-17(11)27-18/h1-6,8,16,22-24,26H,7H2/t16-/m0/s1
SMILES:  c1cc(ccc1[C@@H]1CC(=O)c2c(cc3c(c4cc(c(cc4o3)O)O)c2O1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL9464
PubChem CID:   10407286
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002614] Furanoflavonoids and dihydrofuranoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12643908]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[20189399]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT43 Individual Protein Tyrosinase Agaricus bisporus Inhibition < 10.4 % PMID[487863]
NPT32 Organism Mus musculus Mus musculus Inhibition = 0.0 % PMID[487862]
NPT32 Organism Mus musculus Mus musculus Inhibition = 28.6 % PMID[487862]
NPT32 Organism Mus musculus Mus musculus Inhibition = 40.5 % PMID[487862]
NPT32 Organism Mus musculus Mus musculus Inhibition = 55.0 % PMID[487862]
NPT2 Others Unspecified Inhibition = -1.1 % PMID[487863]
NPT2 Others Unspecified Inhibition = 10.1 % PMID[487863]
NPT2 Others Unspecified Inhibition = 19.5 % PMID[487863]
NPT2 Others Unspecified Inhibition = 40.3 % PMID[487863]
NPT27 Others Unspecified Inhibition < 8.8 % PMID[487863]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC28589 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC248593
0.9506 High Similarity NPC277480
0.9448 High Similarity NPC50394
0.9444 High Similarity NPC37183
0.9337 High Similarity NPC310794
0.9325 High Similarity NPC38914
0.9277 High Similarity NPC174700
0.9212 High Similarity NPC241820
0.9212 High Similarity NPC247973
0.9186 High Similarity NPC47905
0.9186 High Similarity NPC73929
0.9186 High Similarity NPC139683
0.9172 High Similarity NPC475783
0.9146 High Similarity NPC473313
0.9146 High Similarity NPC329669
0.9146 High Similarity NPC472278
0.9141 High Similarity NPC188486
0.9128 High Similarity NPC304322
0.9112 High Similarity NPC49667
0.9112 High Similarity NPC8127
0.9107 High Similarity NPC261471
0.9107 High Similarity NPC473834
0.9102 High Similarity NPC131866
0.9096 High Similarity NPC470704
0.9085 High Similarity NPC84515
0.9085 High Similarity NPC312056
0.9062 High Similarity NPC125300
0.9053 High Similarity NPC287243
0.9048 High Similarity NPC230619
0.9048 High Similarity NPC54098
0.9042 High Similarity NPC202470
0.9036 High Similarity NPC272560
0.9036 High Similarity NPC320741
0.9036 High Similarity NPC171985
0.9036 High Similarity NPC224851
0.9018 High Similarity NPC196879
0.9018 High Similarity NPC16935
0.9006 High Similarity NPC104682
0.9 High Similarity NPC164384
0.9 High Similarity NPC204515
0.8994 High Similarity NPC82217
0.8994 High Similarity NPC216842
0.8994 High Similarity NPC476640
0.8994 High Similarity NPC65885
0.8988 High Similarity NPC190351
0.8988 High Similarity NPC218533
0.8988 High Similarity NPC78830
0.8988 High Similarity NPC472276
0.8982 High Similarity NPC86477
0.8976 High Similarity NPC326520
0.8976 High Similarity NPC472277
0.8976 High Similarity NPC29411
0.8976 High Similarity NPC259757
0.8976 High Similarity NPC473286
0.8976 High Similarity NPC291110
0.897 High Similarity NPC81679
0.897 High Similarity NPC476247
0.8957 High Similarity NPC210084
0.8957 High Similarity NPC99597
0.8951 High Similarity NPC113906
0.8947 High Similarity NPC265380
0.8935 High Similarity NPC212038
0.8935 High Similarity NPC271848
0.8935 High Similarity NPC81332
0.8935 High Similarity NPC262580
0.8935 High Similarity NPC289396
0.8929 High Similarity NPC107627
0.8929 High Similarity NPC53252
0.8929 High Similarity NPC288813
0.8929 High Similarity NPC152477
0.8922 High Similarity NPC128293
0.8922 High Similarity NPC170245
0.8922 High Similarity NPC173292
0.8916 High Similarity NPC18100
0.8916 High Similarity NPC124038
0.8916 High Similarity NPC1755
0.8916 High Similarity NPC133065
0.8916 High Similarity NPC263092
0.8916 High Similarity NPC273959
0.8916 High Similarity NPC59295
0.8916 High Similarity NPC39305
0.8916 High Similarity NPC205265
0.8916 High Similarity NPC472281
0.8916 High Similarity NPC472581
0.8916 High Similarity NPC1706
0.8916 High Similarity NPC38591
0.8909 High Similarity NPC74854
0.8909 High Similarity NPC45124
0.8909 High Similarity NPC30655
0.8909 High Similarity NPC258331
0.8909 High Similarity NPC228383
0.8909 High Similarity NPC472275
0.8909 High Similarity NPC142252
0.8902 High Similarity NPC172770
0.8902 High Similarity NPC250214
0.8902 High Similarity NPC95936
0.8902 High Similarity NPC185258
0.8896 High Similarity NPC235165
0.8896 High Similarity NPC45131
0.8896 High Similarity NPC255106
0.8895 High Similarity NPC324742
0.8895 High Similarity NPC183843
0.8895 High Similarity NPC185275
0.8889 High Similarity NPC192083
0.8889 High Similarity NPC1477
0.8889 High Similarity NPC213608
0.8889 High Similarity NPC213896
0.8882 High Similarity NPC37606
0.8882 High Similarity NPC117450
0.8882 High Similarity NPC149846
0.8876 High Similarity NPC476641
0.8876 High Similarity NPC279209
0.8876 High Similarity NPC102277
0.8875 High Similarity NPC183959
0.8875 High Similarity NPC1612
0.8869 High Similarity NPC243877
0.8869 High Similarity NPC260266
0.8869 High Similarity NPC14662
0.8862 High Similarity NPC108433
0.8862 High Similarity NPC45449
0.8862 High Similarity NPC39306
0.8862 High Similarity NPC300053
0.8862 High Similarity NPC36320
0.8855 High Similarity NPC472448
0.8855 High Similarity NPC83922
0.8855 High Similarity NPC329760
0.8855 High Similarity NPC238995
0.8855 High Similarity NPC220912
0.8848 High Similarity NPC476283
0.8848 High Similarity NPC328102
0.8848 High Similarity NPC472624
0.8844 High Similarity NPC97523
0.8841 High Similarity NPC474208
0.8841 High Similarity NPC156057
0.8841 High Similarity NPC48208
0.8841 High Similarity NPC474836
0.8841 High Similarity NPC162869
0.8841 High Similarity NPC475267
0.8841 High Similarity NPC291508
0.8841 High Similarity NPC79053
0.8841 High Similarity NPC262286
0.8841 High Similarity NPC78225
0.8841 High Similarity NPC36852
0.8841 High Similarity NPC65504
0.8841 High Similarity NPC471209
0.8841 High Similarity NPC223787
0.8837 High Similarity NPC471789
0.8834 High Similarity NPC2928
0.8834 High Similarity NPC321779
0.8827 High Similarity NPC5871
0.8827 High Similarity NPC253872
0.8827 High Similarity NPC106976
0.8824 High Similarity NPC257667
0.8824 High Similarity NPC186847
0.8824 High Similarity NPC472454
0.8824 High Similarity NPC121333
0.882 High Similarity NPC62042
0.8817 High Similarity NPC242395
0.8817 High Similarity NPC300307
0.8814 High Similarity NPC60848
0.8812 High Similarity NPC294852
0.8812 High Similarity NPC321011
0.8812 High Similarity NPC276930
0.8812 High Similarity NPC188679
0.8812 High Similarity NPC194856
0.881 High Similarity NPC235610
0.8802 High Similarity NPC109180
0.8802 High Similarity NPC475985
0.8802 High Similarity NPC470178
0.8802 High Similarity NPC65846
0.8795 High Similarity NPC304387
0.8795 High Similarity NPC29876
0.8795 High Similarity NPC167678
0.8795 High Similarity NPC266314
0.8795 High Similarity NPC32694
0.8795 High Similarity NPC134783
0.8795 High Similarity NPC308992
0.8793 High Similarity NPC150977
0.8793 High Similarity NPC228209
0.8788 High Similarity NPC53545
0.8788 High Similarity NPC469658
0.8788 High Similarity NPC329091
0.8788 High Similarity NPC472877
0.8788 High Similarity NPC40583
0.8788 High Similarity NPC117418
0.8788 High Similarity NPC210459
0.8786 High Similarity NPC476273
0.878 High Similarity NPC137100
0.878 High Similarity NPC195796
0.878 High Similarity NPC472916
0.878 High Similarity NPC68093
0.878 High Similarity NPC208152
0.878 High Similarity NPC191146
0.878 High Similarity NPC278778
0.878 High Similarity NPC472461
0.878 High Similarity NPC138243
0.878 High Similarity NPC201837
0.878 High Similarity NPC142339
0.878 High Similarity NPC78492
0.878 High Similarity NPC291878

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC28589 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8889 High Similarity NPD2393 Clinical (unspecified phase)
0.8735 High Similarity NPD5494 Approved
0.8712 High Similarity NPD1934 Approved
0.8554 High Similarity NPD4868 Clinical (unspecified phase)
0.8545 High Similarity NPD2801 Approved
0.8529 High Similarity NPD6168 Clinical (unspecified phase)
0.8529 High Similarity NPD6167 Clinical (unspecified phase)
0.8529 High Similarity NPD6166 Phase 2
0.8503 High Similarity NPD3749 Approved
0.8494 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD1247 Approved
0.8447 Intermediate Similarity NPD1511 Approved
0.8443 Intermediate Similarity NPD3882 Suspended
0.843 Intermediate Similarity NPD3818 Discontinued
0.8382 Intermediate Similarity NPD5844 Phase 1
0.8364 Intermediate Similarity NPD4380 Phase 2
0.8353 Intermediate Similarity NPD6959 Discontinued
0.8344 Intermediate Similarity NPD1512 Approved
0.8314 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD7411 Suspended
0.825 Intermediate Similarity NPD1549 Phase 2
0.8239 Intermediate Similarity NPD6559 Discontinued
0.8192 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD7074 Phase 3
0.8092 Intermediate Similarity NPD6232 Discontinued
0.807 Intermediate Similarity NPD7075 Discontinued
0.807 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7054 Approved
0.8061 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD7473 Discontinued
0.8023 Intermediate Similarity NPD7472 Approved
0.8012 Intermediate Similarity NPD7768 Phase 2
0.8 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7819 Suspended
0.8 Intermediate Similarity NPD1465 Phase 2
0.7978 Intermediate Similarity NPD6797 Phase 2
0.795 Intermediate Similarity NPD1510 Phase 2
0.7943 Intermediate Similarity NPD3926 Phase 2
0.7933 Intermediate Similarity NPD7251 Discontinued
0.7923 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD919 Approved
0.7857 Intermediate Similarity NPD920 Approved
0.7853 Intermediate Similarity NPD2344 Approved
0.7849 Intermediate Similarity NPD5402 Approved
0.7849 Intermediate Similarity NPD3817 Phase 2
0.7844 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD943 Approved
0.7791 Intermediate Similarity NPD2796 Approved
0.779 Intermediate Similarity NPD7808 Phase 3
0.7765 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD2800 Approved
0.7733 Intermediate Similarity NPD6801 Discontinued
0.7725 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD3751 Discontinued
0.7702 Intermediate Similarity NPD1240 Approved
0.7665 Intermediate Similarity NPD2309 Approved
0.7661 Intermediate Similarity NPD3226 Approved
0.7651 Intermediate Similarity NPD1243 Approved
0.7633 Intermediate Similarity NPD2533 Approved
0.7633 Intermediate Similarity NPD2534 Approved
0.7633 Intermediate Similarity NPD2532 Approved
0.7607 Intermediate Similarity NPD1607 Approved
0.7605 Intermediate Similarity NPD3750 Approved
0.7593 Intermediate Similarity NPD1613 Approved
0.7593 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD2935 Discontinued
0.7574 Intermediate Similarity NPD6799 Approved
0.7568 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD8312 Approved
0.7554 Intermediate Similarity NPD8313 Approved
0.7553 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD4287 Approved
0.7514 Intermediate Similarity NPD6599 Discontinued
0.7486 Intermediate Similarity NPD3787 Discontinued
0.7471 Intermediate Similarity NPD7390 Discontinued
0.7461 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD5403 Approved
0.7439 Intermediate Similarity NPD230 Phase 1
0.7433 Intermediate Similarity NPD8434 Phase 2
0.7427 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD5401 Approved
0.7427 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD6234 Discontinued
0.741 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD1551 Phase 2
0.7362 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7199 Phase 2
0.7322 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD7228 Approved
0.7321 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD2346 Discontinued
0.7312 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD3748 Approved
0.7293 Intermediate Similarity NPD7229 Phase 3
0.7282 Intermediate Similarity NPD6779 Approved
0.7282 Intermediate Similarity NPD6780 Approved
0.7282 Intermediate Similarity NPD6778 Approved
0.7282 Intermediate Similarity NPD6776 Approved
0.7282 Intermediate Similarity NPD6777 Approved
0.7282 Intermediate Similarity NPD6781 Approved
0.7282 Intermediate Similarity NPD6782 Approved
0.7256 Intermediate Similarity NPD2313 Discontinued
0.7253 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD6190 Approved
0.725 Intermediate Similarity NPD8151 Discontinued
0.7239 Intermediate Similarity NPD4908 Phase 1
0.7232 Intermediate Similarity NPD37 Approved
0.7219 Intermediate Similarity NPD1471 Phase 3
0.7207 Intermediate Similarity NPD4967 Phase 2
0.7207 Intermediate Similarity NPD4965 Approved
0.7207 Intermediate Similarity NPD4966 Approved
0.7204 Intermediate Similarity NPD5953 Discontinued
0.7202 Intermediate Similarity NPD2799 Discontinued
0.72 Intermediate Similarity NPD1653 Approved
0.7198 Intermediate Similarity NPD5710 Approved
0.7198 Intermediate Similarity NPD5711 Approved
0.7193 Intermediate Similarity NPD4628 Phase 3
0.7191 Intermediate Similarity NPD8455 Phase 2
0.7189 Intermediate Similarity NPD7286 Phase 2
0.7178 Intermediate Similarity NPD7783 Phase 2
0.7178 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD7435 Discontinued
0.7168 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD5405 Approved
0.716 Intermediate Similarity NPD5406 Approved
0.716 Intermediate Similarity NPD5408 Approved
0.716 Intermediate Similarity NPD5404 Approved
0.7158 Intermediate Similarity NPD8150 Discontinued
0.7151 Intermediate Similarity NPD2296 Approved
0.7136 Intermediate Similarity NPD7871 Phase 2
0.7136 Intermediate Similarity NPD7870 Phase 2
0.7128 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD447 Suspended
0.7125 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD4360 Phase 2
0.7113 Intermediate Similarity NPD4363 Phase 3
0.7104 Intermediate Similarity NPD6808 Phase 2
0.7095 Intermediate Similarity NPD5760 Phase 2
0.7095 Intermediate Similarity NPD5761 Phase 2
0.7093 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD3027 Phase 3
0.7085 Intermediate Similarity NPD7697 Approved
0.7085 Intermediate Similarity NPD7696 Phase 3
0.7085 Intermediate Similarity NPD7698 Approved
0.7074 Intermediate Similarity NPD7685 Pre-registration
0.7073 Intermediate Similarity NPD2861 Phase 2
0.7059 Intermediate Similarity NPD6100 Approved
0.7059 Intermediate Similarity NPD6099 Approved
0.7048 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD3764 Approved
0.7039 Intermediate Similarity NPD6844 Discontinued
0.7035 Intermediate Similarity NPD6823 Phase 2
0.703 Intermediate Similarity NPD7701 Phase 2
0.7026 Intermediate Similarity NPD6534 Approved
0.7026 Intermediate Similarity NPD6535 Approved
0.7019 Intermediate Similarity NPD4665 Approved
0.7019 Intermediate Similarity NPD1610 Phase 2
0.7019 Intermediate Similarity NPD4111 Phase 1
0.6994 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6651 Approved
0.697 Remote Similarity NPD9494 Approved
0.6961 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7874 Approved
0.6952 Remote Similarity NPD7177 Discontinued
0.6952 Remote Similarity NPD7907 Approved
0.6952 Remote Similarity NPD2163 Approved
0.6951 Remote Similarity NPD1203 Approved
0.6951 Remote Similarity NPD1470 Approved
0.6944 Remote Similarity NPD6279 Approved
0.6944 Remote Similarity NPD6280 Approved
0.6935 Remote Similarity NPD2403 Approved
0.6927 Remote Similarity NPD7801 Approved
0.6923 Remote Similarity NPD1933 Approved
0.6919 Remote Similarity NPD7700 Phase 2
0.6919 Remote Similarity NPD7699 Phase 2
0.6904 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6904 Remote Similarity NPD4361 Phase 2
0.6897 Remote Similarity NPD7584 Approved
0.6895 Remote Similarity NPD7240 Approved
0.6889 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6886 Remote Similarity NPD4625 Phase 3
0.6878 Remote Similarity NPD1729 Discontinued
0.6872 Remote Similarity NPD7458 Discontinued
0.6871 Remote Similarity NPD9269 Phase 2
0.6859 Remote Similarity NPD7549 Discontinued
0.6848 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6845 Remote Similarity NPD3268 Approved
0.6845 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1899 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data